Perceptive Advisors’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$10.7M Buy
+250,000
New +$13.6M 0.16% 79
2026
Q1
Sell
-979,000
Closed -$93.3M 102
2025
Q4
$93.3M Buy
979,000
+669,000
+216% +$65.6M 1.66% 19
2025
Q3
$30.3M Buy
310,000
+30,000
+11% +$3.11M 0.87% 35
2025
Q2
$30.1M Buy
280,000
+150,000
+115% +$15.2M 1.12% 25
2025
Q1
$13.1M Buy
+130,000
New +$13.1M 0.46% 43
2017
Q2
Sell
-3
Closed 139
2017
Q1
$0 Hold
3
﹤0.01% 170
2016
Q4
$0 Buy
+3
New +$65 ﹤0.01% 189

Other funds holding BSX

Perceptive Advisors's BSX Position: Q2 2026 in Review

Perceptive Advisors opened a new position in Boston Scientific (BSX) in Q2 2026: 250,000 shares worth $10.7M. The stake represents 0.16% of the portfolio and ranks #79 among its holdings. This is a return to the name: Perceptive Advisors previously reported a position in BSX as recently as Q4 2025.

Perceptive Advisors first reported a position in BSX in Q4 2016 and has held it in 7 quarters since. The position peaked at $93.3M in Q4 2025. 1,468 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Perceptive Advisors held 250,000 shares of Boston Scientific worth $10.7M as of Q2 2026.
  • Boston Scientific was a new Perceptive Advisors position in Q2 2026.
  • Boston Scientific made up 0.16% of Perceptive Advisors's portfolio in Q2 2026, its #79 holding.
  • Perceptive Advisors first reported a position in Boston Scientific in Q4 2016 and has held it in 7 quarters since.
  • Perceptive Advisors's Boston Scientific position peaked at $93.3M in Q4 2025.
  • 1,468 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Perceptive Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.